OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway
Daichi Nomoto, Yoshifumi Baba, Yang Liu, et al.
Cancer Letters (2022) Vol. 530, pp. 59-67
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy
Jiaao Sun, Feng Chen, Guangzhen Wu
The ISME Journal (2023) Vol. 17, Iss. 10, pp. 1535-1551
Open Access | Times Cited: 41

Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases
Eman K. E. Anwer, Muhammad Ajagbe, Mohamed Sherif, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 100-100
Open Access | Times Cited: 1

Fusobacterium nucleatum promotes colorectal cancer liver metastasis via miR-5692a/IL-8 axis by inducing epithelial-mesenchymal transition
Yulong Yu, Han Yin, Bili Wu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1

Intra-tumoral bacteria in breast cancer and intervention strategies
Ting Hou, Xiaoling Huang, Jiahui Lai, et al.
Advanced Drug Delivery Reviews (2025), pp. 115516-115516
Closed Access | Times Cited: 1

Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma
Yiqiu Li, Shan Xing, Fangfang Chen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33

Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer
Wei Zhang, Yibao Fan, Jinze Zhang, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101005-101005
Open Access | Times Cited: 27

Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma
Songhe Guo, Fangfang Chen, Linfang Li, et al.
Journal of Advanced Research (2023) Vol. 61, pp. 165-178
Open Access | Times Cited: 22

Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
Xueli Yang, Chang Tian, Qian Yuan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29

NOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers
Yujie Zhou, Songyan Yu, Wenyong Zhang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14511-14511
Open Access | Times Cited: 21

Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1‐CXCR2 axis
Masataka Hayashi, Naoki Ikenaga, Kohei Nakata, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3666-3678
Open Access | Times Cited: 20

Fusobacterium nucleatum: a novel immune modulator in breast cancer?
Alexa Little, Mark Tangney, Michael M. Tunney, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 18

Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL‐32/PRTN3 expression
Jing Lei, Feng Xu, Chao Deng, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2414-2428
Open Access | Times Cited: 17

Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation
Camille Martin‐Gallausiaux, Laurène Salesse, Diego García‐Weber, et al.
Gut Microbes (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 17

Periodontal pathogens and cancer development
Yuxi Zhou, Joerg Meyle, Sabine Groeger
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 112-149
Open Access | Times Cited: 7

Oral microbiota: the overlooked catalyst in cancer initiation and progression
Xinlin Wang, Xin He, Bin Zhong
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access

The role of oral microbiota in cancer
Zhou Lan, Weijia Liu, Hao Cui, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15

RIPK2: a promising target for cancer treatment
Jieqiong You, Yanru Wang, Haifeng Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14

Cancer‐Associated Fibroblast‐Secreted Exosomes Regulate Macrophage Polarization in Pancreatic Cancer via the NOD1 Pathway
Wenxin Yang, Yuanyuan Zheng, Han Zhou, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 1
Closed Access

The role of microbiota in esophageal squamous cell carcinoma: A review of the literature
Hsueh‐Chien Chiang, Michael W. Hughes, Wei‐Lun Chang
Thoracic Cancer (2023) Vol. 14, Iss. 28, pp. 2821-2829
Open Access | Times Cited: 12

Relationship between gut microbiome Fusobacterium nucleatum and LINE-1 methylation level in esophageal cancer
Yoshifumi Baba, Yoshihiro Hara, Tasuku Toihata, et al.
Esophagus (2023) Vol. 20, Iss. 4, pp. 704-712
Closed Access | Times Cited: 11

Page 1 - Next Page

Scroll to top